Axol Bioscience

Axol Bioscience, following its merger with Censo, offers contract research services using advanced iPSC technology to create diverse human cell types from small tissue samples. This technology is crucial for studying diseases like Alzheimer’s, where obtaining living tissue is difficult. It supports drug discovery in neurodegenerative, neuroinflammatory, and cardiotoxicity areas, providing high-quality in vitro models and custom lab services to major biopharma companies globally. Its expertise in neuro-inflammation and pain research attracts clients from Europe, the US, and Japan, driving life science discovery forward with innovative, human-relevant models.